Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Tool Uses Deep Learning for Precision Cancer Therapy

By LabMedica International staff writers
Posted on 16 Sep 2025

Nearly 50 new cancer therapies are approved each year, but selecting the right one for patients with highly individual tumor characteristics remains a major challenge. More...

Physicians struggle to navigate the growing number of options and determine which treatment will bring the most benefit. To address this complexity, researchers have developed a new artificial intelligence (AI) tool to integrate diverse data sources and guide more precise, personalized therapy decisions.

Unlike traditional methods, the AI-powered toolkit named Flexynesis, which has been developed by researchers at the Max Delbrück Center (Berlin, Germany), combines deep neural networks with multimodal data analysis, including multi-omics datasets, medical imaging, and clinical text. By processing this variety of inputs simultaneously, the system enables physicians to improve diagnosis, prognosis, and treatment strategies across multiple cancer types.

Flexynesis was designed as a flexible and accessible toolkit, packaged for use across platforms such as PyPI, Guix, Docker, Bioconda, and Galaxy. Researchers validated its effectiveness through translational projects with medical doctors, identifying biomarkers that align with disease outcomes. The study, published in Nature Communications, highlights its versatility in answering diverse clinical questions, from identifying tumor types to predicting drug effectiveness and survival outcomes.

The tool can identify suitable biomarkers, improve cancer subtype classification, and even locate the primary tumor when metastases of unknown origin are present. Its design makes it a valuable complement to existing AI tools like Onconaut, offering a broader capability for multimodal integration. While widespread clinical use is limited by the availability of multi-omics data, increasing adoption in hospital tumor boards and research programs suggests this barrier may soon be overcome.

"Comparable tools so far have often been either difficult to use or only useful for answering certain questions,” said Dr. Altuna Akalin, senior author of the study. "Flexynesis, by contrast, can answer various medical questions at the same time: for example, what type of cancer is involved, what drugs are particularly effective in this case, and how these will affect the patient's chances of survival.”

Related Links:
Max Delbrück Center


New
Gold Member
Hybrid Pipette
SWITCH
Portable Electronic Pipette
Mini 96
8-Channel Pipette
SAPPHIRE 20–300 µL
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Technology

view channel
Image: The technology could be used for the early diagnosis of diseases such as cancers and Alzheimer\'s (Photo courtesy of PolyU)

3D Micro-Printed Sensors to Advance On-Chip Biosensing for Early Disease Detection

Early-stage disease diagnosis depends on the ability to detect biomarkers with exceptional sensitivity and precision. However, traditional biosensing technologies struggle with achieving this at the micro-scale,... Read more

Industry

view channel
Image: ELITechGroup’s unique Real-Time PCR technologies include the revolutionary Minor Groove Binder (Photo courtesy of ELITechGroup)

ELITech and Hitachi High-Tech to Develop Automated PCR Testing System for Infectious Diseases

Molecular testing has become central to diagnosing and monitoring infectious diseases by analyzing genetic information. The use of PCR during the COVID-19 pandemic showed its value, but traditional systems... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.